3 unstoppable ASX 200 shares to buy and hold forever

These shares have smashed the market and look well-placed to continue this trend.

| More on:
A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the best ways to build your wealth is by investing in ASX 200 shares that can grow strongly over long periods.

But not all shares are capable of doing this. So, let's take a look at three unstoppable shares that have incredible track records and positive long-term growth outlooks.

They are as follows:

REA Group Ltd (ASX: REA)

REA Group is an unstoppable ASX 200 share that has made investors rich. Over the past 15 years, the realestate.com.au operator's shares have delivered an average total return of 20.8% per annum.

Its property platforms are embedded in how Australians buy and sell homes. That network effect has been built over decades and is incredibly difficult to replicate.

What drives REA's compounding is not just property market activity, but its ability to increase revenue per customer. Premium listings, data tools, and value-added services allow the company to grow even when transaction volumes are not booming.

Given its domination of the local market and its growing Indian business, the future looks bright for this ASX share.

ResMed Inc. (ASX: RMD)

Another ASX 200 share that has delivered strong returns for investors is ResMed. It has achieved an average total return of 16.95% per annum since 2016.

This medical device company operates in sleep apnoea and respiratory care, which are areas driven by long-term health trends rather than discretionary spending. Diagnosis rates continue to rise, and once patients are on therapy, they tend to stay there.

What makes ResMed particularly effective at compounding is how it blends hardware with software and data. Devices, masks, cloud platforms, and analytics all work together to create recurring revenue and long-term customer relationships.

Management estimates that the total addressable market for sleep apnoea is over 1 billion people. This gives ResMed a significant growth runway for the next decade and beyond.

TechnologyOne Ltd (ASX: TNE)

Finally, TechnologyOne is a classic example of quiet compounding. Over the past decade, this ASX 200 share has delivered an average total return of 20.2% per annum.

The company provides mission-critical software to governments, universities, and large organisations. These customers do not switch systems lightly, which gives TechnologyOne a sticky client base and highly predictable revenue.

In addition, its shift to a software-as-a-service model has been highly successful and fundamentally changed the business. Revenue visibility has improved, cash generation has strengthened, and recurring income has become a much larger part of the mix.

And with management confident that it can double in size every five years, this ASX share could be destined to outperform long into the future.

Motley Fool contributor James Mickleboro has positions in REA Group, ResMed, and Technology One. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and Technology One. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A youthful man looks up thoughtfully at a light bulb above his head.
Share Market News

2 quality ASX shares near 52-week lows worth watching

Two proven businesses. Heavy sell-offs. Is the market offering opportunity?

Read more »

A humanoid robot is pictured looking at a share price chart
Share Market News

What is happening to these ASX software shares?

The recent sell off seems driven by renewed concerns around valuations and AI-driven disruption.

Read more »

Two kids are selling big ideas from a lemonade stand on the side of the road for cheap!
Growth Shares

Experts rate this ASX share as a buy!

A leading fund manager is calling this growing business a buy.

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Growth Shares

2 ASX 200 shares that could be top buys for growth

I’m expecting these two ASX 200 shares to deliver good growth to 2030.

Read more »

A man leaps from a stack of gold coins to the next, each one higher than the last.
Growth Shares

3 quality ASX shares to buy with $10,000

Brokers see upside for these well-run businesses.

Read more »

Growth Shares

These beaten down ASX growth shares could rise 50% to 75%

These growth shares are down but not out according to analysts.

Read more »

A older man and younger man rest, exhausted but happy after a good boxing session.
Growth Shares

Why these battered ASX shares deserve a second look

These stocks might be bruised, but not down and out.

Read more »

Three small children reach up to hold a toy rocket high above their heads in a green field with a blue sky above them.
Growth Shares

These 4 ASX 200 stocks could jump another 70% to 80% in 2026

These stocks are expected to rocket higher.

Read more »